Enerbank Japan
Series B in 2024
Enerbank Japan is engaged in the development and operation of an electric power auction system designed to simplify energy production and consumption. The company offers a corporate power reverse auction service that enables users to transition from retail electric power companies to more optimal and cost-effective power contracts across Japan. In addition to facilitating power switching, Enerbank issues green power certificates, promoting sustainable energy practices. The company also operates a media business that supports clients in achieving efficient power management and cost reduction without complications.
Rege Nephro
Series B in 2024
Rege Nephro is a Kyoto-based biotechnology company focused on renal disease therapeutics. It conducts research and development, production, and marketing of therapies based on nephron progenitor cells, and develops kidney organoids used to screen nephrotoxicity in drug discovery. The company is leveraging induced pluripotent stem cell technology from the Center for iPS Cell Research and Application at Kyoto University to develop cell-based therapies for kidney conditions, along with potential applications for liver and pancreas diseases. Founded in 2019, Rege Nephro aims to reduce dialysis dependence by addressing renal failure through regenerative approaches.
Renalys Pharma
Series A in 2024
Renalys Pharma is a private, late-stage clinical biopharmaceutical firm in Japan dedicated on developing new therapies that address unmet needs in the management of renal illness in Japanese and Asian patients.
Metagen Therapeutics
Series A in 2023
Metagen Therapeutics is a drug discovery and development company that leverages microbiome science, with a focus on the gut microbiome to advance pharmaceuticals, healthcare solutions, functional foods, and academic research. Formed as a joint venture between Fast Track Initiative Co., Ltd. and Keio Innovation Co., Ltd., the company aims to unlock microbiome-based therapies and collaborative approaches across industry and academia.
LUCA Science
Series B in 2022
LUCA Science Inc. is a biotechnology company based in Japan that specializes in developing innovative mitochondrial therapies aimed at restoring cellular bioenergetics in damaged tissues and organs. Utilizing patented iMIT technology, the company creates a novel platform of highly functional mitochondria, which can be supplied to affected areas to enhance bioenergetics and restore normal cellular functions. By harnessing mitochondria as biopharmaceutical agents, LUCA Science aims to address a range of unmet medical needs and improve disease states through the stabilization and control of mitochondrial activity. This groundbreaking approach positions LUCA Science at the forefront of mitochondrial therapy, with the potential to significantly impact the treatment landscape for various health conditions.
Utill, founded in 2015 and based in Tokyo, Japan, is a company that specializes in web design and application development. It provides a range of services including production business, which encompasses LP production, HP/site creation, graphic design, web service development, and system development. Additionally, Utill offers in-house services such as "Web Secretary" for web production consultation, "Video Secretary" for video production consultation, and "System Secretary" for system development consultation. These services are designed to help businesses effectively promote their digital transformation (DX) initiatives.
MFS, Inc. is a Tokyo-based company that specializes in consumer lending services, primarily focusing on online mortgage offerings. Established in 2009, MFS simplifies the mortgage process by eliminating the need for customers to search for, apply for, or negotiate with traditional financial institutions. The company has garnered significant media attention and has been featured in prominent outlets such as NHK, Nihon Keizai Shimbun, and Yomiuri Shimbun, highlighting its innovative approach to the mortgage industry in Japan.
Nyle
Debt Financing in 2021
Nyle Inc. is a web consulting company based in Tokyo, Japan, specializing in web solutions and internet media services. Founded in 2007, the company offers various platforms, including Appliv, which helps users discover smartphone applications, and Appliv Games. Nyle Inc. was previously known as Volare Inc. before rebranding in September 2007.
Nyle
Venture Round in 2021
Nyle Inc. is a web consulting company based in Tokyo, Japan, specializing in web solutions and internet media services. Founded in 2007, the company offers various platforms, including Appliv, which helps users discover smartphone applications, and Appliv Games. Nyle Inc. was previously known as Volare Inc. before rebranding in September 2007.
LUCA Science
Series A in 2020
LUCA Science Inc. is a biotechnology company based in Japan that specializes in developing innovative mitochondrial therapies aimed at restoring cellular bioenergetics in damaged tissues and organs. Utilizing patented iMIT technology, the company creates a novel platform of highly functional mitochondria, which can be supplied to affected areas to enhance bioenergetics and restore normal cellular functions. By harnessing mitochondria as biopharmaceutical agents, LUCA Science aims to address a range of unmet medical needs and improve disease states through the stabilization and control of mitochondrial activity. This groundbreaking approach positions LUCA Science at the forefront of mitochondrial therapy, with the potential to significantly impact the treatment landscape for various health conditions.
Blue Innovation
Venture Round in 2020
Blue Innovation Co., Ltd., established in 1999 and headquartered in Tokyo, Japan, specializes in developing and implementing unmanned aerial vehicle (UAV) solutions. The company creates optimized drones and their components, along with a proprietary platform, Blue Earth, which facilitates the remote, automated control and coordination of multiple drones for various applications. These include security, indoor inspection, education and safety, entertainment, and logistics services. Blue Innovation also engages in research and development projects, system development, and general operations, contributing to Japan's UAS Industry Promotion Council (JUIDA) as its secretariat.
TVISION INSIGHTS
Venture Round in 2020
TVISION INSIGHTS Co. Ltd., founded in 2015 and headquartered in Tokyo, Japan, specializes in media research focused on television. The company utilizes advanced human body recognition technology to measure and analyze the "viewing quality" of TV commercials and programs. This innovative approach allows TVISION INSIGHTS to capture unique data on TV viewing behavior in living rooms, creating a comprehensive dataset that is uncommon in the industry. With an emphasis on global expansion, the company has established additional offices in Boston and New York, and continues to pursue growth opportunities across various markets. By addressing the evolving challenges of the television landscape, TVISION INSIGHTS aims to unlock the full potential of TV as a medium.
WizWe
Venture Round in 2019
WizWe Co., Ltd. is a technology company based in Tokyo, Japan, founded in 2018. It specializes in the planning, development, and management of a platform aimed at enhancing learning habits through technological support in language education. The company offers an online learning platform that provides innovative training programs and linguistic tools for multiple languages, including English, Japanese, and Chinese. By utilizing effective mechanisms, WizWe facilitates users' language acquisition and aims to improve their overall learning experience.
TransRecog
Venture Round in 2019
Founded in 2017, TransRecog specializes in developing innovative software solutions. Its flagship product, AxelaNote, is a PDF writing application for Windows that enables users to edit protected PDFs and save modifications separately from the original files.
Talent and Assessment
Venture Round in 2019
Talent and Assessment Inc. is a Tokyo-based company, founded in 2014, that specializes in developing an AI-driven recruitment platform known as SHaiN. This innovative application provides artificial intelligence-based interviewing services that allow candidates to participate in interviews anytime and anywhere using their smartphones. The platform utilizes unique strategic hiring methods to analyze candidates’ qualifications and offers diagnostic reports on their performance. By engaging applicants interactively, the AI assesses their responses and provides clients with detailed evaluations, which enhance recruitment efficiency and streamline the hiring process. Talent and Assessment’s focus on cutting-edge HR technology positions it as a leader in the talent acquisition sector.
AlterBooth
Series A in 2019
Founded in 2015, AlterBooth specializes in designing and developing software systems leveraging cloud computing technology. It offers products like kosmisch for micro data center conversion and cloud pointer for Microsoft Azure support. The company also provides IT services, focusing on architectural design for cloud-native applications.
AlphaNavi Pharma
Series A in 2019
AlphaNavi Pharma Co., Ltd. is a biotechnology company based in Kyoto, Japan, founded in 2019. The company focuses on drug discovery, specifically developing novel therapeutics for pain management. It is engaged in research and development of voltage-gated sodium channel selective inhibitors, with its primary products being ANP-230 and ANP-231, which are aimed at treating peripheral neuropathic pain. AlphaNavi Pharma collaborates with academic institutions and investors to enhance its research and clinical development efforts, striving to create innovative analgesic drugs that alleviate pain for patients and improve their quality of life.
Chordia Therapeutics
Series B in 2019
Chordia Therapeutics Inc. is a clinical-stage biotechnology company based in Fujisawa, Japan, founded in 2017. The company specializes in the research and development of innovative oncology drugs, focusing on delivering first-in-class therapies for cancers that currently have high unmet medical needs. Chordia Therapeutics is committed to advancing new therapeutic options to patients as swiftly as possible, aiming to address significant gaps in cancer treatment.
MILIZE
Corporate Round in 2018
MILIZE develops a cloud-based web platform integrating financial engineering with AI research, development, and operations. Its products include AI-driven forecasting tools for sales, investments, and life planning, along with risk management support.
Logbar
Venture Round in 2018
Logbar Inc. is a Japanese company founded in 2013, specializing in the development of innovative communication devices and wearable technology. Its flagship products include Ring ZERO, a gesture-controlled device that enables users to interact with smartphones, tablets, and various electronics through hand gestures, and iLi, recognized as the world's first wearable translator designed for travelers. iLi functions independently without requiring an internet connection, facilitating seamless communication across language barriers. Logbar aims to enhance the ease of communication through its advanced technology, offering solutions that transform gestures into digital actions, allowing users to send texts, control home appliances, and manage other tasks efficiently. Based in Tokyo, Logbar is focused on creating new opportunities for interaction and connectivity.
Note, Inc., formerly known as Piece of Cake, Inc., is a Japanese company founded in 2011 and based in Minato. It operates an online platform designed to help content creators publish various types of media, including text, images, and audio, over the internet. The platform facilitates updates for users, enabling them to stay informed with daily information while fostering a comfortable environment for both creators and readers to share and receive content pleasantly.
Nanolux develops imaging sensors and infrared color night vision technology for cameras and related systems. The company designs and manufactures night vision cameras and electronic device systems used in security, surveillance, and related applications, including in-vehicle and medical imaging. Its technology allows capture of infrared images in complete darkness, enabling data collection without visible illumination. Founded in 2012 and based in Tsukuba, Japan, Nanolux aims to support safe and efficient social infrastructure and medical sectors through unobtrusive imaging solutions.
Meijo Nano Carbon
Venture Round in 2018
Meijo Nano Carbon Co., Ltd. specializes in the manufacture of carbon nanotube chemicals, focusing on both single-walled and multi-walled carbon nanotubes. Established in 2005 and based in Nagoya, Japan, the company produces a range of products, including single-walled carbon nanotubes with uniform diameters and categorized as metallic or semiconducting types. Meijo Nano Carbon also creates carbon nanotube dispersions, such as specialized inks for various applications, and carbon nanotube-coated dishes. The company's innovative synthesis technology allows its products to serve as lightweight alternatives to traditional conductive materials like copper, making them valuable for industries such as aerospace, automotive, and petrochemicals. With properties like superior conductivity and reduced weight, Meijo Nano Carbon's offerings are positioned to enhance the performance and efficiency of various applications.
Local Works
Venture Round in 2018
Local Works Inc. is a Tokyo-based company founded in 2014 that operates a housing renovation and store interior construction price comparison platform. This platform serves as a construction rate comparison tool, allowing users to search for and evaluate various remodeling companies based on rates, quality, and reliability. By providing comprehensive information on construction costs and contractor dependability, Local Works enables clients to easily identify suitable and trustworthy contractors for their renovation projects.
Perseus Proteomics
Venture Round in 2018
Perseus Proteomics Inc. is a biotechnology company based in Tokyo, Japan, focused on drug discovery. Established in 2001, it specializes in antibody discovery, engineering, and research support activities. The company engages in target discovery and functional protein expression, offering services such as mouse hybridoma sequencing, recombinant protein production, and contract research for antibodies. Additionally, Perseus Proteomics develops, manufactures, and supplies a range of antibody products. By leveraging advanced antibody technology, the company aims to create innovative medicines that address the needs of patients worldwide seeking improved medical care.
Kotozna
Venture Round in 2018
Kotozna, Inc. is an innovative IT service company based in Tokyo, Japan, founded in 2016. The company specializes in developing mobile applications that provide real-time multilingual translation services, addressing the social challenge of language barriers. Its flagship product, Kotozna Chat, allows users to communicate across various messaging platforms with instantaneous translation, facilitating seamless interaction for international travelers and local businesses. Additionally, Kotozna offers Kotozna Camera, which translates Japanese content, such as restaurant menus, through QR code scanning. By leveraging advanced technologies like AI and machine translation, Kotozna aims to enhance communication for enterprises and enable them to effectively engage with customers in a global market.
Himuka AM Pharma
Venture Round in 2018
Himuka AM Pharma is a pharmaceutical company dedicated to the research and development of Adrenomedullin derivatives. Founded in 2017, it focuses on creating drug candidates based on the bioactive peptide adrenomedullin for mucosal healing and clinical remission.
Audiostock
Venture Round in 2018
Audiostock Inc. is a Japanese company that operates an online platform for music creators, allowing them to showcase and share their audio works. Founded in 2007 in Okayama, Japan, the company provides tools for musicians to monetize their creations by facilitating the buying and selling of music licenses. Audiostock supports not only musicians but also video creators, enabling them to source music for their projects. The platform allows users to register their music, sell usage rights, and earn royalties based on sales, thereby creating a marketplace that benefits both music creators and clients in the industry seeking to publish and utilize sound materials.
Wonderplanet
Venture Round in 2018
Founded in 2012, Wonderplanet specializes in designing and developing native language applications and games for smartphones and tablets. Its offerings include 2D and 3D games for iOS and Android platforms.
Blue Innovation
Venture Round in 2018
Blue Innovation Co., Ltd., established in 1999 and headquartered in Tokyo, Japan, specializes in developing and implementing unmanned aerial vehicle (UAV) solutions. The company creates optimized drones and their components, along with a proprietary platform, Blue Earth, which facilitates the remote, automated control and coordination of multiple drones for various applications. These include security, indoor inspection, education and safety, entertainment, and logistics services. Blue Innovation also engages in research and development projects, system development, and general operations, contributing to Japan's UAS Industry Promotion Council (JUIDA) as its secretariat.
PREVENT
Seed Round in 2018
PREVENT Inc. is a healthcare company based in Nagoya, Japan, founded in 2016. It specializes in the prevention of lifestyle-related diseases through innovative medical data analysis and mobile technology. The company develops Mystar, a mobile application designed to support health promotion for patients with conditions such as diabetes, hypertension, and ischemic heart disease. Mystar enables users to log their health data, engage in communication with healthcare providers, and access educational materials based on research to enhance their lifestyle habits. Additionally, PREVENT offers Myscope, which analyzes health examination data to provide predictive simulations and insights for lifestyle improvements. By leveraging academic medical expertise and advanced technology, PREVENT aims to reduce the risk of severe illnesses and enhance the overall health of its users.
EdiGENE Japan
Series A in 2017
EdiGENE Japan, now known as Modalis Therapeutics Corporation, is an emerging biotechnology company based in Tokyo, Japan. Founded in 2016, it specializes in the research and development of innovative therapeutics aimed at addressing serious genetic disorders. The company utilizes its proprietary CRISPR-GNDM technology, which allows for locus-specific modulation of gene expression and histone modification without the necessity for double-stranded DNA cleavage or traditional gene editing techniques. Modalis Therapeutics has established a solid intellectual property foundation, including licenses from the University of Tokyo, to support its focus on developing treatments for orphan genetic diseases and other unmet medical needs.
StemRIM
Venture Round in 2017
StemRIM is a biotechnology company based in Ibaraki, Japan, founded in 2006, specializing in the development of regeneration-guided medicines for treating intractable diseases. The company focuses on innovative research and development of therapies that mobilize stem cells within the body to promote healing in various conditions, including epidermolysis bullosa, cerebral infarction, and myocardial infarction. StemRIM offers a range of products, including regeneration-inducing peptides and proteins, as well as therapeutic autologous cell collection devices and stem cell gene therapy technologies. The company aims to advance regenerative medicine by creating treatments that facilitate functional tissue regeneration without the need for external stem cell extraction.
Tokiwa Bio
Venture Round in 2017
Tokiwa Bio Inc. is a Japanese company based in Tsukuba that specializes in the development and manufacturing of drugs for regenerative medicine, particularly focusing on gene therapy. Founded in 2014, the company utilizes artificially synthesized vectors to introduce multiple genes into the cytoplasm of cells without causing damage to the existing genetic material. This innovative approach facilitates the creation of gene therapy drugs aimed at treating rare diseases, including hemophilia and ischemia. In addition to its gene therapy efforts, Tokiwa Bio also produces biopharmaceuticals, antibody drugs, and research reagents, positioning itself as a key player in the biopharmaceutical industry.
Unifinity
Venture Round in 2017
Unifinity Inc. is a Tokyo-based company that specializes in developing a no-code platform for mobile application creation aimed at businesses. Established in 2006 and formerly known as Cresco Communications, the company rebranded in 2014. Unifinity's flagship product, Unifinity Wizard, enables users to generate fully functional application prototypes within ten minutes, requiring no coding skills. This platform allows organizations to customize applications to meet their specific needs and is complemented by Unifinity Studio, a comprehensive low-code development tool. By facilitating in-house application development through a variety of templates, Unifinity significantly reduces both the time and cost associated with the app development process, empowering non-engineers to participate in creating effective business solutions.
APTJ
Venture Round in 2017
Automotive Platform Technology Japan (APTJ) focuses on the development, sale, and licensing of automotive software and hardware products. Established on September 16, 2015, the company specializes in creating onboard control systems for domestic vehicles. APTJ's software is designed to comply with Automotive Open System Architecture (AUTOSAR) specifications, providing vehicle manufacturers with user-friendly solutions that streamline their development processes. Through its innovative offerings, APTJ aims to enhance the efficiency and effectiveness of automotive technology integration.
Blue Innovation
Venture Round in 2016
Blue Innovation Co., Ltd., established in 1999 and headquartered in Tokyo, Japan, specializes in developing and implementing unmanned aerial vehicle (UAV) solutions. The company creates optimized drones and their components, along with a proprietary platform, Blue Earth, which facilitates the remote, automated control and coordination of multiple drones for various applications. These include security, indoor inspection, education and safety, entertainment, and logistics services. Blue Innovation also engages in research and development projects, system development, and general operations, contributing to Japan's UAS Industry Promotion Council (JUIDA) as its secretariat.
EdiGENE Japan
Seed Round in 2016
EdiGENE Japan, now known as Modalis Therapeutics Corporation, is an emerging biotechnology company based in Tokyo, Japan. Founded in 2016, it specializes in the research and development of innovative therapeutics aimed at addressing serious genetic disorders. The company utilizes its proprietary CRISPR-GNDM technology, which allows for locus-specific modulation of gene expression and histone modification without the necessity for double-stranded DNA cleavage or traditional gene editing techniques. Modalis Therapeutics has established a solid intellectual property foundation, including licenses from the University of Tokyo, to support its focus on developing treatments for orphan genetic diseases and other unmet medical needs.
Ancar is an online marketplace in Japan that enables direct buying and selling of used cars without intermediaries. The platform connects buyers and sellers, displays basic vehicle information and photos, and supports services such as maintenance inspections, transportation, and ownership transfers, as well as warranties to foster secure online transactions. By reducing reliance on intermediaries and commissions, Ancar aims to provide access to affordable second-hand cars while offering safety features and trusted information through partner services.
Momotaro-Gene
Venture Round in 2016
Momotaro-Gene Inc., established in 2007 and headquartered in Okayama, Japan, is a biotechnology company focused on developing innovative cancer treatments. The company specializes in creating tumor-suppressor genes, with notable products including reduced expression in immortalized cells (REIC) for therapeutic purposes and interleukin-12 (IL-12) as an immunostimulant. Momotaro-Gene's mission is to advance drug discovery and bring effective cancer treatments to market.
Local Works
Venture Round in 2016
Local Works Inc. is a Tokyo-based company founded in 2014 that operates a housing renovation and store interior construction price comparison platform. This platform serves as a construction rate comparison tool, allowing users to search for and evaluate various remodeling companies based on rates, quality, and reliability. By providing comprehensive information on construction costs and contractor dependability, Local Works enables clients to easily identify suitable and trustworthy contractors for their renovation projects.
APTJ
Venture Round in 2016
Automotive Platform Technology Japan (APTJ) focuses on the development, sale, and licensing of automotive software and hardware products. Established on September 16, 2015, the company specializes in creating onboard control systems for domestic vehicles. APTJ's software is designed to comply with Automotive Open System Architecture (AUTOSAR) specifications, providing vehicle manufacturers with user-friendly solutions that streamline their development processes. Through its innovative offerings, APTJ aims to enhance the efficiency and effectiveness of automotive technology integration.
Cacco
Venture Round in 2016
Founded in Tokyo, Japan in 2011, Cacco specializes in providing data science-based software solutions and support services to businesses primarily in Japan. The company offers fraud detection algorithms, payment consulting services, and data science solutions designed to enhance business decision-making processes.
PREVENT
Seed Round in 2016
PREVENT Inc. is a healthcare company based in Nagoya, Japan, founded in 2016. It specializes in the prevention of lifestyle-related diseases through innovative medical data analysis and mobile technology. The company develops Mystar, a mobile application designed to support health promotion for patients with conditions such as diabetes, hypertension, and ischemic heart disease. Mystar enables users to log their health data, engage in communication with healthcare providers, and access educational materials based on research to enhance their lifestyle habits. Additionally, PREVENT offers Myscope, which analyzes health examination data to provide predictive simulations and insights for lifestyle improvements. By leveraging academic medical expertise and advanced technology, PREVENT aims to reduce the risk of severe illnesses and enhance the overall health of its users.
Ricksoft
Venture Round in 2015
Ricksoft is a Tokyo-based software company that provides system integration, cloud services, and software development for enterprise customers in Japan. It offers systems integration design, construction, customization, migration, and operation support, along with tool training. The company develops and markets project management software, including WBS Gantt-Chart for Jira, and offers usability enhancements and digital transformation tools such as Alfresco connectors. Ricksoft also provides software design, development, distribution, configuration, plugin development, and performance tuning services, information system consulting, and on-site demonstrations and training. It sells licenses for its products and services. Founded in 2005, Ricksoft focuses on helping organizations visualize and manage project progress, control issues, and optimize deployment through its add-ons and consulting services. Headquartered in Tokyo, Japan.
Magellan Systems Japan
Venture Round in 2015
Magellan Systems Japan, Inc. is a company dedicated to the research, development, and licensing of high-precision satellite positioning systems. Founded in 1987 and headquartered in Amagasaki, Japan, the company specializes in a range of technologies including semi-software and software global positioning systems (GPS), digital signal processing systems, and multi-frequency global navigation satellite systems (GNSS). It also develops advanced GNSS real-time kinematic systems and inertial measurement systems, providing solutions for GPS timing and autonomous ephemeris prediction. In addition to its core development activities, Magellan Systems Japan imports and sells GNSS-related products, supporting the utilization of artificial satellite technology in various applications.
Delta-Fly Pharma
Venture Round in 2015
Delta-Fly Pharma, Inc. is a Japan-based biotechnology company focused on the discovery and development of gentle anti-cancer agents. Founded in 2010 and headquartered in Tokushima, the company utilizes innovative modular technology to create treatments aimed at minimizing side effects associated with traditional cancer therapies. The name "Delta-Fly" is inspired by the dragonfly, symbolizing resilience and progress, reflecting the company's commitment to advancing cancer care through its unique therapeutic approaches.
EST Corporation
Venture Round in 2015
EST Corporation, founded in 2007 and based in Tokyo, Japan, specializes in providing medical treatment and healthcare services. The company focuses on electronic health services designed for medical associations and institutions. EST Corporation offers solutions that facilitate data creation and the computerization of life function evaluations, particularly targeting elderly care and secondary prevention. Their services include a medical appointment management system, which assists clients in efficiently managing healthcare appointments and improving patient care.
Leading Mark
Series A in 2015
Leading Mark Inc. is an employment agency based in Tokyo, Japan, specializing in human resources services. The company is focused on streamlining the recruitment process through its online platform, which aggregates job listings tailored to users' interests. This approach aims to enhance the job-seeking experience by prioritizing the needs of applicants, in contrast to larger, traditional agencies that may focus more on the hiring companies. Additionally, Leading Mark is expanding its operations to include mid-career and international hiring, with a dedicated team in China working to connect top Japanese-speaking Chinese students with domestic employers. By emphasizing a user-centric model, Leading Mark seeks to alleviate the frustrations often faced by job seekers, ensuring they receive the information and opportunities they need to advance their careers.
Grooves
Venture Round in 2014
Grooves is a Tokyo-based provider of a social recruiting platform that develops and operates software to connect engineers, candidates, recruiters, and agencies, aiming to streamline the recruitment process. The platform serves Japan and the Asia-Pacific region and has supported thousands of corporate customers since 2004.
SCIVAX
Venture Round in 2014
Founded in 2004 and headquartered in Kawasaki, Japan, SCIVAX specializes in nanotechnology services. It offers comprehensive solutions ranging from optical simulation of nanostructures to mold production and mass manufacturing.
3rdKind
Venture Round in 2014
3rdKind Inc. is a Tokyo-based smartphone game publisher established in 2011. The company specializes in assisting overseas game developers with marketing, localization, and cultural adaptation to effectively penetrate the Japanese market. Its services encompass a range of support functions, including publicity, sales forecasting, and promotional activities, ensuring that games are tailored and marketed appropriately for local audiences. 3rdKind collaborates with partners such as the mobile operator KDDI to distribute games across major Japanese app stores, including App Store and Google Play. By providing comprehensive digital marketing services, 3rdKind aims to facilitate the successful launch and distribution of mobile gaming applications, helping clients expand their business in Japan.
Regimmune
Series D in 2014
REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an additional office in San Francisco, California. Founded in 2006, the company specializes in the discovery and development of immune-regulatory therapeutics aimed at treating severe diseases and disorders related to the immune system. Utilizing its proprietary reVax technology, REGiMMUNE targets immune tolerance by inducing regulatory T cells, which can address a variety of conditions such as Graft versus Host Disease, type 1 diabetes, rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. The company has one clinical-stage compound, RGI-2001, currently in a Phase I/II trial for GvHD associated with hematopoietic stem cell transplantation, and a second product, RGI-3001, in preclinical development for type 1 diabetes. With a pipeline that includes several promising compounds, REGiMMUNE aims to provide innovative treatments that minimize the side effects commonly associated with traditional immunosuppressants.
GLM Co., Ltd. is a car development and manufacturing company based in Kyoto, Japan, specializing in electric vehicles. Founded in 2010, GLM focuses on creating a low-carbon society through its innovative electric car designs. The company's vehicles are known for their customizable chassis and advanced electric vehicle systems, which integrate various motors, inverters, battery modules, and vehicle control units. This combination aims to deliver an exciting and unique driving experience for users while contributing to environmental sustainability.
SMARTInsight
Series A in 2013
SMART Insight Corporation, headquartered in Chiyoda-ku, Tokyo, specializes in developing and providing big data analysis software. The company has created a cloud version of its visualization software, SMART/InSight Cloud, which integrates data from various sources into comprehensible visual formats. This software is primarily utilized in the manufacturing sector but is now being tailored for a broader range of industries. By leveraging Amazon CloudSearch, SMART/InSight Cloud enables flexible cross-sectional searches and effective data visualization. Its cloud-based application features a usage-based billing model, allowing users to customize their systems according to their data volume needs while maintaining cost efficiency.
Nyle Inc. is a web consulting company based in Tokyo, Japan, specializing in web solutions and internet media services. Founded in 2007, the company offers various platforms, including Appliv, which helps users discover smartphone applications, and Appliv Games. Nyle Inc. was previously known as Volare Inc. before rebranding in September 2007.
Questetra
Series C in 2013
Questetra, Inc. is an enterprise cloud computing company based in Kyoto, Japan, founded in 2008. It specializes in providing business process management (BPM) tools designed to enhance productivity and optimize various workflows for organizations. The Questetra BPM Suite allows users to independently develop and manage BPMN-driven workflows through a 100% web-based interface, enabling both process design and task execution directly in a browser. The platform includes a variety of sample processes, such as estimate generation and invoice issuance, and offers seamless integration with Google Apps, allowing users to log in with their Google accounts and export data to Google Docs. Additionally, Questetra provides BPM consulting services to further support organizations in their process improvement initiatives.
AdInte
Venture Round in 2013
AdInte Co., Ltd. is a company based in Kyoto, Japan, that specializes in developing an advertising delivery platform tailored for smartphone advertising. Founded in 2009, AdInte offers a range of services including demand side platform (DSP) advertising, web marketing, search engine optimization (SEO), and the management of a dental job site. The company also provides original ad network solutions and website creation services. With a focus on mobile internet, AdInte serves clients in both Japan and South Korea, delivering online and online-to-offline (O2O) advertising solutions.
Yaraku
Venture Round in 2013
Yaraku is an online platform that enables users to translate documents of multiple languages. It was launched in August 2009 and is based in Tokyo, Japan.
TableCheck
Venture Round in 2012
TableCheck Inc, founded in 2011 and based in Chuo-ku, Japan, develops a mobile application that offers restaurant information and booking options. The company's software includes table management and customer relationship management features, enhancing guest engagement, reservations, and table utilization for restaurants worldwide. TableCheck analyzes restaurant data to create vibrant dining experiences and provides tools that enable seamless customer interactions from the moment of reservation.
Ubiregi
Debt Financing in 2012
Ubiregi develops and provides a SaaS-based point-of-sale (POS) system for businesses in Japan. Founded in 2010, the company is headquartered in Shibuya-ku with an additional office in Osaka.
Grooves
Seed Round in 2012
Grooves is a Tokyo-based provider of a social recruiting platform that develops and operates software to connect engineers, candidates, recruiters, and agencies, aiming to streamline the recruitment process. The platform serves Japan and the Asia-Pacific region and has supported thousands of corporate customers since 2004.
Gene Techno Science
Venture Round in 2010
Founded in 2001, Gene Techno Science is a Japanese biopharmaceutical company dedicated to researching and developing innovative drugs. Its portfolio includes treatments for immunological, cardiovascular, ophthalmic, infectious, renal diseases, and oncology.
Bplats, Inc. is a privately held company based in Tokyo, Japan, founded in 2006. The company specializes in cloud and Software as a Service (SaaS) distribution and billing solutions, aiming to enhance the adoption of these technologies across Japan. Bplats operates through three nationwide distribution channels and also assists North American and European SaaS companies in entering the Japanese and Chinese markets. The founding team of Bplats originated from Mitsui Co. Ltd. and built upon the foundation of License Online, which is now owned by Softbank BB. Bplats offers a range of services that support essential business functions, including sales, contract management, billing, and channel management, thereby facilitating a smoother integration of cloud solutions for its clients.
Bplats, Inc. is a privately held company based in Tokyo, Japan, founded in 2006. The company specializes in cloud and Software as a Service (SaaS) distribution and billing solutions, aiming to enhance the adoption of these technologies across Japan. Bplats operates through three nationwide distribution channels and also assists North American and European SaaS companies in entering the Japanese and Chinese markets. The founding team of Bplats originated from Mitsui Co. Ltd. and built upon the foundation of License Online, which is now owned by Softbank BB. Bplats offers a range of services that support essential business functions, including sales, contract management, billing, and channel management, thereby facilitating a smoother integration of cloud solutions for its clients.
Kringle Pharma
Venture Round in 2007
Kringle Pharma is a Japanese biopharmaceutical company focused on the research and development of hepatocyte growth factor (HGF)–based protein medicines and NK4 therapies. The company aims to leverage HGF’s regenerative properties and NK4’s antiangiogenic activity to address organ repair and cancer indications. Its pipeline includes recombinant human HGF for acute renal failure, spinal cord injury, and CNS diseases, as well as recombinant NK4 and NK4 gene therapies for cancer. Founded in 2001, the company operates in the Japanese market.
CellSeed
Venture Round in 2005
CellSeed specializes in regenerative medicine, developing products primarily for Japan and Europe. Its portfolio includes epithelial cell sheets for corneal and esophageal regeneration, cardiac patches for heart diseases, periodontal tissue regeneration, and cartilage sheets for treating osteoarthritis.
DeNA is a Japanese technology and services company that develops and operates mobile services, including free-to-play games and the Mobage social games platform, which hosts first-, second-, and third-party games on localized networks for mobile devices and PCs. The company also offers e-commerce services, operating platforms such as DeNA Shopping and Mobaoku for online auctions, along with other web services. Its businesses include social media and internet marketing services in its Social Media segment, and various ancillary ventures such as travel and insurance agency services and professional baseball-related activities under its Others segment. DeNA serves global users with its mobile and online platforms, and its flagship Mobage platform is central to its mobile gaming ecosystem.